Q32 Bio (QTTB) Asset Utilization Ratio (2018 - 2024)
Q32 Bio (QTTB) posted quarterly Asset Utilization Ratio of 0.01 for Q3 2024, down 120.87% year-over-year from 0.06 in Q4 2023, and down 429.49% quarter-over-quarter from 0.0 in Q2 2024.
Q32 Bio (QTTB) Asset Utilization Ratio (2018 - 2024) Analysis & Trends
Q32 Bio's Asset Utilization Ratio history runs 7 years deep, the most recent figure standing at 0.01 for Q3 2024.
- In Q3 2024, Asset Utilization Ratio fell 120.87% year-over-year to 0.01; the TTM figure through Sep 2024 stood at 0.01 (down 120.87% YoY), while the FY2025 annual figure was 0.7, changed N/A from the prior year.
- Asset Utilization Ratio for Q3 2024 stood at 0.01, down from 0.0 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.15 in Q4 2021, with the low at 0.01 in Q3 2024.
- The 5-year median for Asset Utilization Ratio is 0.02 (2022), against an average of 0.05.
- The sharpest annual moves came in 2021 and 2024: Asset Utilization Ratio surged 1804.26% in 2021, then tumbled 120.87% in 2024.
- Q32 Bio's Asset Utilization Ratio stood at 0.01 in 2020, then soared by 1298.06% to 0.15 in 2021, then sank by 91.49% to 0.01 in 2022, then jumped by 444.15% to 0.07 in 2023, then plunged by 116.73% to 0.01 in 2024.
- Business Quant data shows QTTB's Asset Utilization Ratio at 0.01 in Q3 2024, 0.0 in Q2 2024, and 0.04 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Q32 Bio | 359.61 Mn | 253.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -0.01 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.04 |
| Dec 31, 2023 | 0.07 |
| Sep 30, 2023 | 0.06 |
| Jun 30, 2023 | 0.04 |
| Mar 31, 2023 | 0.03 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.15 |
| Sep 30, 2021 | 0.14 |
| Jun 30, 2021 | 0.13 |
| Mar 31, 2021 | 0.13 |
| Dec 31, 2020 | 0.01 |
| Sep 30, 2020 | 0.01 |
| Jun 30, 2020 | 0.01 |
| Mar 31, 2020 | 0.01 |
| Dec 31, 2019 | 0.01 |